Puma Biotechnology Reports Inducement Awards under Nasdaq Listing Rule 56354 MarketScreener

LOS ANGELES – Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 2, 2023, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 22,500 shares of Puma common stock to three new non-executive employees. The awards were granted…Read More